Effect of Insulin Receptor-Knockdown on the Expression Levels of Blood–Brain Barrier Functional Proteins in Human Brain Microvascular Endothelial Cells
Authors:
- 22 November 2021
- journal article
- research article
- Published by Springer Nature in Pharmaceutical Research
- Vol. 39 (7) , 1561-1574
Abstract
Purpose The insulin receptor (INSR) mediates insulin signaling to modulate cellular functions. Although INSR is expressed at the blood–brain barrier (BBB), its role in the modulation of BBB function is poorly understood. Therefore, in this study, we aimed to analyze the effect of INSR knockdown on the expression levels of functional proteins at the BBB. Methods We established the INSR-knockdown cell line (shINSR) using human cerebral microvascular endothelial cells (hCMEC/D3). The cellular proteome was analyzed using quantitative proteomics. Results INSR mRNA and protein expressions were decreased in shINSR cells. The suppression of INSR-mediated signaling in shINSR cells was evaluated. The proteins involved in glycolysis and glycogenolysis were suppressed in shINSR cells. As amyloid-β peptide-related proteins, the expressions of presenilin-1 was increased, and those of the insulin-degrading enzyme and neprilysin were decreased. The expressions of BBB transporters, including the ABCB1/MDR1, ABCG2/BCRP, and SLCO2A1/OATP2A1 were significantly decreased by more than 50% in shINSR cells. The efflux activity of ABCB1/MDR1 was also suppressed. The expressions of the low-density lipoprotein receptor-related protein 1 were significantly increased, and those of the transferrin receptor were significantly decreased in shINSR cells. The expression of claudin-5 was also suppressed in shINSR cells. Conclusions The present study suggests that INSR-mediated signaling is involved in the regulation of functional protein expression at the BBB and contributes to the maintenance of BBB function. Changes in the expressions of amyloid-β peptide-related proteins may contribute to the development of cerebral amyloid angiopathy via the suppression of INSR-mediated signaling.Keywords
Funding Information
- Japan Society for the Promotion of Science (21H02649)
- Core Research for Evolutional Science and Technology (JP171024167)
This publication has 70 references indexed in Scilit:
- Iron deficiency on neuronal functionBioMetals, 2012
- HIF-1 activation induces doxorubicin resistance in MCF7 3-D spheroids via P-glycoprotein expression: a potential model of the chemo-resistance of invasive micropapillary carcinoma of the breastBMC Cancer, 2012
- Attenuation of prostaglandin E2 elimination across the mouse blood-brain barrier in lipopolysaccharide-induced inflammation and additive inhibitory effect of cefmetazoleFluids and Barriers of the CNS, 2011
- Drug Targeting of Erythropoietin Across the Primate Blood-Brain Barrier with an IgG Molecular Trojan HorseThe Journal of Pharmacology and Experimental Therapeutics, 2010
- Type 1 diabetes exaggerates features of Alzheimer's disease in APP transgenic miceExperimental Neurology, 2010
- Unbiased Quantitation of Escherichia coli Membrane Proteome Using Phase Transfer SurfactantsMolecular & Cellular Proteomics, 2009
- Expression and localization of prostaglandin transporter in Alzheimer disease brains and age-matched controlsJournal of Neuroimmunology, 2008
- Phase Transfer Surfactant-Aided Trypsin Digestion for Membrane Proteome AnalysisJournal of Proteome Research, 2008
- Iron, brain ageing and neurodegenerative disordersNature Reviews Neuroscience, 2004
- KEGG: Kyoto Encyclopedia of Genes and GenomesNucleic Acids Research, 2000